This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.
Special deals for our readers
Are you qualified for the Visa Black Card?
The World’s Most Prestigious and Versatile Credit Card. Apply Now!
Be a more profitable investor:
What’s Jim Cramer trading in his personal portfolio? Click here
Get an Equifax 3-in-1 Credit Report Now!
Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing.
Find out why TradeKing.com was ranked #1 Discount Broker by SmartMoney Magazine two years running! (August 2006 & 2007).
Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition!
LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount.
Get FICO Score Watch Now!
Free Quicken Online automatically categorizes your expenses.
Click here to get access to powerful investing tools only available at Investor’s Business Daily.
Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here
Altus Pharmaceuticals
(NASDAQ: ALTU)
Dr. Georges Gemayel, CEO
br />
Altus Pharmaceuticals Inc. (Altus) is a biopharmaceutical company focused on the development of oral and injectable protein therapeutics for gastrointestinal and metabolic disorders. The Company’s product candidates are based on its technology, which enables the crystallization of proteins for use as therapeutic drugs. The Company is developing its product candidate, ALTU-238, by applying crystallization technology. During the year ended December 31, 2008, Altus had crystallized more than 70 proteins for use in its research and development programs.